Novel cuproptosis related long non-coding RNA signature in oral squamous cell carcinoma prognosis and immunotherapy
Abstract
Cuproptosis, a recently identified copper-dependent regulated cell death, is increasingly recognized for its relevance in cancer biology. In their study, Kong L et al. have developed a four long non-coding RNA (lncRNA) cuproptosis-related prognostic signature that effectively stratifies oral squamous cell carcinoma (OSCC) patients. The study reveals distinct immune microenvironment patterns with implications for immunotherapy response. Their experimental validation of STARD4-AS1 further supports biological relevance. This comment underscores the importance of integrating cuproptosis biology with lncRNA profiling to enhance prognostic accuracy and inform therapeutic strategies in OSCC. It also emphasizes the need for external validation and detailed mechanistic studies to support clinical translation.
Read the paper
Related studies
- Regulation of nucleolus assembly by non-coding RNA polymerase II transcripts
- For a Healthy Histone Code, a Little SUMO in the Tail Keeps the Acetyl Away
- Discovering a binary CTCF code with a little help from BORIS
- Article Commentary: Stabilizing the Code–-Methods to Preserve RNA Prove Their Worth
- Foreword to the Special Issue for the RINTC (The Implicit Seismic Risk of Code-Conforming Structures) Project
- Commentary: Promoting Health and Well-being in Pediatric Primary Care Settings: Using Health and Behavior Codes at Routine Well-child Visits
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.